Extensive-stage SCLC

Clinical trials for Extensive-stage SCLC explained in plain language.

Never miss a new study

Get alerted when new Extensive-stage SCLC trials appear

Sign up with your email to follow new studies for Extensive-stage SCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Engineered immune cells take aim at stubborn lung cancer

Disease control Recruiting now

This trial is testing a new type of cell therapy for adults with small cell lung cancer that has returned or not responded to standard treatments. The therapy uses immune cells called natural killer (NK) cells, engineered to recognize and attack cancer cells through two targets a…

Matched conditions: EXTENSIVE-STAGE SCLC

Phase 1/2 • Sponsor: Beijing Biotech • Aim: Disease control

Last updated Aug 06, 2026 00:00 UTC

Extensive-stage SCLC

Get alerted when new Extensive-stage SCLC trials appear

Engineered immune cells take aim at stubborn lung cancer